Poland· PL-100243308

Doxorubicinum Accord

A doxorubicin product containing doxorubicini hydrochloridum, registered in Poland by Accord Healthcare Polska Sp. z o.o.. The same ATC class is registered in 17 of our 19 countries.

ATC L01DB01

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about doxorubicini hydrochloridumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Doxorubicin is registered in 17 of 19 countries.

Countries holding a registration under ATC L01DB01 (doxorubicin), each read from that country’s own register.

This record: Poland, from URPL (Poland)
10 of them publish a price we can compare per daily dose

Search doxorubicin products by name

Doxorubicin · ATC L01DB01

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of doxorubicin costs, country by country.

Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Doxorubicin · price per daily dose (5 mg)

USD · FX 28 Sept 2026

CH Switzerland$12.19

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Doxorubicini hydrochloridum
Manufacturer: Accord Healthcare Polska Sp. z o.o.
Country: Poland (PL)
ATC code: L01DB01
ATC class: Doxorubicin
Defined daily dose: 5 mg, P
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 5

gtin
05909990851386
gtin
05909990851393
gtin
05909990851409
gtin
05909991030599
gtin
05909991141882

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

775 interactions on record for doxorubicin.

Graded by severity as the source publishes them — 98 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check doxorubicin against other medicines How interaction checks work

Doxorubicin · interactions on record

775 records

98 severe
383 moderate
29 minor
265 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
QuinidineC01BA01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Doxorubicin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All doxorubicin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Adriblastin, Doxorubicin Accord
Belgium · Adriblastina Ready To Use, Doxorubicin Accord Healthcare
Bulgaria · Доксорубицин Акорд
Cyprus · Adriblastina
Czechia · Doxorubicin Ebewe, Doxorubicin Medac
Germany · Adriacept Blasen-Instillations-Set, Adrimedac
Denmark · Adriamycin, Doxorubicin Accord
Estonia · Doxorubicin Accord
Spain · Doxorubicina Accord, Doxorubicina Aurovitas
Finland · Doxorubicin Accord, Doxorubicin Medac
France · Adriblastine, Doxorubicin Teva
United Kingdom (Northern Ireland) · Doxorubicin Accord Healthcare, Doxorubicin Hydrochloride Medac
Greece · Adriblastina, Doxiprol
Croatia · Doxorubicin Pliva, Sindroxocin
Hungary · Doxorubicin Accord, Doxorubicin Sandoz
Ireland · Doxorubicin Accord Healthcare Ireland, Doxorubicin Rivopharm
Iceland · Caelyx Pegylated Liposomal, Doxorubicin Medac
Italy · Adriblastina, Doxorubicin Teva
Liechtenstein · Caelyx Pegylated Liposomal, Myocet Liposomal
Lithuania · Doxorubicin Accord, Doxorubicin Ebewe
Luxembourg · Adriblastina Ready To Use, Doxorubicine Teva
Latvia · Doxorubicin Accord
Malta · Doxorubicin Accord Healthcare
Netherlands · Doxorubicin Hydrochloride Eugia, Doxorubicine Accord
Norway · Adriamycin, Caelyx Pegylated Liposomal
Portugal · Doxorrubicina Accord, Doxorrubicina Aurovitas
Romania · Doxlox, Doxorubicină Accord
Sweden · Doxorubicin Accord, Doxorubicin Ebewe
Slovenia · Doksorubicin Accord, Doksorubicin Sandoz
Slovakia · Doxorubicin Medac, Doxorubicin Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b5511ac1-c1fa-4bc4-93e4-58bf6eee9744
GET /v1/drugs/b5511ac1-c1fa-4bc4-93e4-58bf6eee9744?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Koncentrat do sporządzania roztworu do infuzji",
  "source": "urpl",
  "strength": "2 mg/ml",
  "packaging": "05909990851386 ¦ Lz ¦ 65086\n1 fiol. 5 ml\n05909990851393 ¦ Lz ¦ 65087\n1 fiol. 25 ml\n05909990851409 ¦ Lz ¦ 65088\n1 fiol. 100 ml\n05909991030599 ¦ Lz ¦ 81314\n1 fiol. 10 ml\n05909991141882 ¦ Lz ¦ 92035\n1 fiol. 50 ml",
  "substance": "Doxorubicini hydrochloridum 2 mg/ml",
  "common_name": "Doxorubicini hydrochloridum",
  "pl_product_id": "100243308",
  "pozwolenie_nr": "17953",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about doxorubicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console